Endothelial TLR4 in Vascular Senescence and Targeted Senotherapeutics
Current understanding
Endothelial TLR4 is proposed as a context- and cell-type-dependent driver of vascular senescence linking sterile DAMP sensing to endothelial inflammatory and senescence programs that propagate to the broader vascular wall [expert-opinion]. The review frames systemic pan-TLR4 blockade as a failed strategy and nominates precision delivery (VCAM-1/E-selectin-targeted nanoparticles, engineered plant exosomes) to achieve spatiotemporally restricted endothelial TLR4 inhibition — a delivery/pitch concept well ahead of any human efficacy data [mechanism-plausible]. Human-translation status: no clinical readouts; concept consolidation of preclinical TLR4-senescence literature.
Evidence log
- 2026-10-01 — Endothelial TLR4 at the Crossroads of Vascular Senescence and Targeted Senotherapeutics.: cross-connection with tlrs-saps2-ppp6c-nfkb-senescence: Both frame TLR→NF-κB signaling as upstream of the senescence program; the endothelial-TLR4 page specifies the cell-type context and delivery problem that the broader TLR–SAPS2/PPP6C–NF-κB axis leaves abstract. (novelty: 3)